Mark For: ECUBE® trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 90187705 |
Registration Number | 6415228 |
Mark Literal Elements | ECUBE |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | SERVICE MARK |
Register | PRINCIPAL |
Current Location | PUBLICATION AND ISSUE SECTION 2021-02-17 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Cindy Hsu |
2020-09-02 | Date of First Use |
2020-09-02 | Date of Use In Commerce |
2020-09-17 | Application Filed |
2020-09-21 | Location: NEW APPLICATION PROCESSING |
2020-09-21 | Status: Live/Pending |
2020-09-21 | Transaction Date |
2021-02-17 | Location: PUBLICATION AND ISSUE SECTION |
2021-03-23 | Published |
2021-03-23 | Status: Application has been published for opposition. The opposition period begins on the date of publication. |
2021-07-13 | Trademark Registered |
Party: | PGI Drug Discovery LLC |
Address | 11811 North Freeway 5th Floor, Unit #709 Houston, TEXAS UNITED STATES 77060 |
Legal Entity Type | Limited Liability Company |
Legal Entity State | DELAWARE |
Application | MULTI | 2020-09-17 |
Drawing | JPEG | 2020-09-17 |
Specimen | JPEG | 2020-09-17 |
summary-SearchSummary2021021114060334505005 | 2021-02-11 | |
Examiner's Amendment | 2021-02-16 | |
Amendment and Mail Process Complete | MULTI | 2021-02-17 |
TRAM Snapshot of App at Pub for Oppostn | MULTI | 2021-02-17 |
Notice of Publication | XML | 2021-03-03 |
Notification Of Notice of Publication | XML | 2021-03-03 |
OG Publication Confirmation | XML | 2021-03-23 |
IC 042. US 100 101. G & S: Medical and scientific research in the field of behavioral, analgesic, psychiatric, neuroprotective, circadian, cognitive and motor capacities on animals; medical and pharmacological phenotype testing for scientific research purposes; Medical and scientific research, namely, pharmaceutical and biotechnological research of human disorders using animal models, specifically, screening and testing of chemical compounds for therapeutic or toxic effects, and capturing, quantifying, processing and storing information on behavioral and physiological changes in animal subjects. FIRST USE: 20200902. FIRST USE IN COMMERCE: 20200902
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0421 | Medical and scientific research in the field of behavioral, analgesic, psychiatric, neuroprotective, circadian, cognitive and motor capacities on animals; medical and pharmacological phenotype testing; research services and scientific developments of apparatus for measuring and accessing electrophysiological responses on animals; Medical and scientific research, namely, pharmaceutical and biotechnological research of human disorders using animal models, specifically, screening and testing of chemical compounds for therapeutic or toxic effects, and capturing, quantifying, processing and storing information on behavioral and physiological changes in animal subjects |
GS0421 | Medical and scientific research in the field of behavioral, analgesic, psychiatric, neuroprotective, circadian, cognitive and motor capacities on animals; medical and pharmacological phenotype testing for scientific research purposes; Medical and scientific research, namely, pharmaceutical and biotechnological research of human disorders using animal models, specifically, screening and testing of chemical compounds for therapeutic or toxic effects, and capturing, quantifying, processing and storing information on behavioral and physiological changes in non-human animal subjects |
Description | Date | Proceeding Number |
---|---|---|
PUBLISHED FOR OPPOSITION | 2021-03-23 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-03-23 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-03-03 | |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-02-16 | |
EXAMINERS AMENDMENT E-MAILED | 2021-02-16 | |
EXAMINERS AMENDMENT -WRITTEN | 2021-02-16 | 92986 |
EXAMINER'S AMENDMENT ENTERED | 2021-02-16 | 88888 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-02-16 | |
ASSIGNED TO EXAMINER | 2021-02-01 | 92986 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-10-26 | |
NEW APPLICATION ENTERED IN TRAM | 2020-09-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.